Presentation The Structural Heart Disease Summit 2018 Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease Presenter: Howard C. Herrmann, Fabian Nietlispach, Marc Gerdisch, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Transcatheter Aortic Valve Replacement for Aortic Insufficiency in an LVAD Patient Presenter: Ashish Pershad, Laura Davidson, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery Presenter: Ashish Pershad, Roberto Spina, MD June 21, 2018
Presentation SCAI 2018 Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement Presenter: Sahil Khera April 28, 2018
Presentation SCAI 2018 3D Printing and Computer Modeling to Predict Paravalvular Leak in Transcatheter Aortic Valve Replacement Presenter: Sergey Gurevich April 28, 2018
Presentation CRT 2018 Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial Presenter: Ron Waksman March 04, 2018
Presentation TCT 2017 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings Presenter: Mayra Guerrero November 01, 2017
Presentation TCT 2017 TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial Presenter: Steven R. Bailey, Patrick W. Serruys, Nicolas M. Van Mieghem November 01, 2017
Presentation TCT 2017 Aortic Valve Replacement for CHF Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Howard C. Herrmann October 31, 2017
Presentation TCT 2017 Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Henrique B. Ribeiro October 31, 2017
Presentation TCT 2017 TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD October 31, 2017
Presentation TCT 2017 TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement Presenter: Reginald I. Low, Michael J. Rinaldi, Richard Jabbour October 31, 2017
Presentation TCT 2017 TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD October 31, 2017
Presentation TCT 2017 TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger October 31, 2017
Presentation TCT 2017 TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD October 31, 2017
Presentation TCT 2017 TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR) Presenter: Peter C. Block, Lars Sondergaard, Daniel J. Blackman October 31, 2017
Presentation TCT 2017 Featured Lecture: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients : Complete 1-Year Outcomes from the SURTAVI Trial Presenter: Martin B. Leon, Patrick T. O'Gara, Nicolas M. Van Mieghem October 30, 2017